Zentalis Pharmaceuticals, Inc. (ZNTL)
Nasdaq: ZNTL · CIK 0001725160 · United States
Every official Zentalis Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ZNTL filings
Zentalis Pharmaceuticals, Inc. documents
- Zentalis Pharmaceuticals, Inc. 10-K 2026ZNTL 10-K 2026: annual report for fiscal 2026
- Zentalis Pharmaceuticals, Inc. 10-K 2025ZNTL 10-K 2025: annual report for fiscal 2025
- Zentalis Pharmaceuticals, Inc. 10-K 2024ZNTL 10-K 2024: annual report for fiscal 2024
- Zentalis Pharmaceuticals, Inc. 10-K 2023ZNTL 10-K 2023: annual report for fiscal 2023
- Zentalis Pharmaceuticals, Inc. 10-K 2022ZNTL 10-K 2022: annual report for fiscal 2022
- Zentalis Pharmaceuticals, Inc. 10-Q 2026ZNTL 10-Q 2026: quarterly report for fiscal 2026
- Zentalis Pharmaceuticals, Inc. 10-Q 2025ZNTL 10-Q 2025: quarterly report for fiscal 2025
- Zentalis Pharmaceuticals, Inc. 10-Q 2024ZNTL 10-Q 2024: quarterly report for fiscal 2024
- Zentalis Pharmaceuticals, Inc. 10-Q 2023ZNTL 10-Q 2023: quarterly report for fiscal 2023
- Zentalis Pharmaceuticals, Inc. 10-Q 2022ZNTL 10-Q 2022: quarterly report for fiscal 2022
- Zentalis Pharmaceuticals, Inc. 8-K 2026ZNTL 8-K 2026: current report for fiscal 2026
- Zentalis Pharmaceuticals, Inc. 8-K 2025ZNTL 8-K 2025: current report for fiscal 2025
- Zentalis Pharmaceuticals, Inc. 8-K 2024ZNTL 8-K 2024: current report for fiscal 2024
- Zentalis Pharmaceuticals, Inc. 8-K 2023ZNTL 8-K 2023: current report for fiscal 2023
- Zentalis Pharmaceuticals, Inc. 8-K 2022ZNTL 8-K 2022: current report for fiscal 2022
- Zentalis Pharmaceuticals, Inc. DEF 14A 2026ZNTL DEF 14A 2026: proxy statement for fiscal 2026
- Zentalis Pharmaceuticals, Inc. DEF 14A 2025ZNTL DEF 14A 2025: proxy statement for fiscal 2025
- Zentalis Pharmaceuticals, Inc. DEF 14A 2024ZNTL DEF 14A 2024: proxy statement for fiscal 2024
- Zentalis Pharmaceuticals, Inc. DEF 14A 2023ZNTL DEF 14A 2023: proxy statement for fiscal 2023
- Zentalis Pharmaceuticals, Inc. DEF 14A 2022ZNTL DEF 14A 2022: proxy statement for fiscal 2022
- Zentalis Pharmaceuticals, Inc. Form 4 2026ZNTL Form 4 2026: insider trading filing for fiscal 2026
- Zentalis Pharmaceuticals, Inc. Form 4 2025ZNTL Form 4 2025: insider trading filing for fiscal 2025
- Zentalis Pharmaceuticals, Inc. Form 4 2024ZNTL Form 4 2024: insider trading filing for fiscal 2024
- Zentalis Pharmaceuticals, Inc. Form 4 2023ZNTL Form 4 2023: insider trading filing for fiscal 2023
- Zentalis Pharmaceuticals, Inc. Form 4 2022ZNTL Form 4 2022: insider trading filing for fiscal 2022
- Zentalis Pharmaceuticals, Inc. S-1 2026ZNTL S-1 2026: registration statement for fiscal 2026
- Zentalis Pharmaceuticals, Inc. S-1 2025ZNTL S-1 2025: registration statement for fiscal 2025
- Zentalis Pharmaceuticals, Inc. S-1 2024ZNTL S-1 2024: registration statement for fiscal 2024
- Zentalis Pharmaceuticals, Inc. S-1 2023ZNTL S-1 2023: registration statement for fiscal 2023
- Zentalis Pharmaceuticals, Inc. S-1 2022ZNTL S-1 2022: registration statement for fiscal 2022
- Zentalis Pharmaceuticals, Inc. 13F 2026ZNTL 13F 2026: institutional holdings for fiscal 2026
- Zentalis Pharmaceuticals, Inc. 13F 2025ZNTL 13F 2025: institutional holdings for fiscal 2025
- Zentalis Pharmaceuticals, Inc. 13F 2024ZNTL 13F 2024: institutional holdings for fiscal 2024
- Zentalis Pharmaceuticals, Inc. 13F 2023ZNTL 13F 2023: institutional holdings for fiscal 2023
- Zentalis Pharmaceuticals, Inc. 13F 2022ZNTL 13F 2022: institutional holdings for fiscal 2022
More companies